Ovarian Cancer Trial Result: Extended survival rate vs. expected survival rate
Expected and Actual Survival Months with
Relative Failed Lines of Chemotherapy and # Cycles of HEATT®
The data showing the extension of life expectancy supports the assertion of the effectiveness of whole-body hyperthermia by Verthermia®. The average expected survival was 7.82 months for all 10 patients . The resulting average survival was 19.7 months (596 days); this increase shows the effectiveness of HEATT® to extend life.